Robert Shaw
Chief Financial Officer
Replay available
Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) Q3 2025 earnings conference call, held 2025-11-12. Replay captured from the company's public earnings webcast.

Chief Financial Officer
President and Chief Executive Officer
Analyst, Maxim Group (for Jason McCarthy)
Analyst, HC Wainwright
Analyst, Alliance Global Partners
Watch the replay and follow the connected company analysis, news, and investor updates for Acurx Pharmaceuticals, Inc..
WEBVTT 00:00:00.031 -- 00:00:05.137 and welcome to the Accrax Pharmaceutical third quarter 2025 conference call and business 00:00:05.137 -- 00:00:09.682 update. At this time, all participants are in a listen-only mode. 00:00:09.682 -- 00:00:13.466 A brief question and answer session will follow the formal presentation. 00:00:13.466 -- 00:00:18.212 If anyone should require operator assistance during the conference, please press star 00:00:18.212 -- 00:00:23.057 zero on your telephone keypad. As a reminder, this conference is being recorded. 00:00:23.057 -- 00:00:28.383 It is now my pleasure to introduce your host, Robert Shaw, Chief Financial Officer. 00:00:28.383 -- 00:00:31.425 Thank you, sir. You may begin. 00:00:31.587 -- 00:00:35.593 Thank you, Maria. Good morning and welcome to our call. 00:00:35.593 -- 00:00:40.761 This morning we issued a press release providing financial results and company highlights 00:00:40.761 -- 00:00:43.746 for the third quarter of 2025, which 00:00:43.746 -- 00:00:47.529 is available on our website at accorexpharma.com. 00:00:48.293 -- 00:00:53.341 Joining me today is Dave Lucci, President and CEO of Accorex, who will give 00:00:53.341 -- 00:00:58.447 a corporate update and outlook. Following that, I'll provide some highlights of the financials 00:00:58.447 -- 00:01:02.350 from the third quarter ended September 30, 2025, 00:01:02.854 -- 00:01:07.220 and then turn the call back over to Dave for his closing remarks. 00:01:07.220 -- 00:01:12.207 As a reminder, during today's call, we'll be making certain forward-looking statements, 00:01:12.207 -- 00:01:16.694 which are based on current information, assumptions, estimates, and projections about 00:01:16.694 -- 00:01:22.448 future events that are subject to change and involve a number of ...